Leo B. Womack, Chairman and CFO - Leo is a Certified Public Accountant and a Registered Securities Broker. He is also the Vice President and Co-founder of Commerce Securities Corporation, a N.A.S.D. Member firm since 1982. He has been involved in numerous life science entities during his career.

James W. Meador, President - Jim has over 24 years of innovative medical product development experience. Scientifically published, and an inventor on over 50 U.S. & foreign patents, he is experienced in medical product development in a diversity of market areas including: cardiovascular, immunology, microbiology, hematology, rehabilitation, drug-abuse, and a variety of specialty consulting areas. He came to Fairway as part of the KVM purchase in 2000. Jim co-founded KVM Technologies, Inc. and was Executive Vice President and Manager for the contract medical product development aspects of the company. This group brought over 40 medical products to market. He was also the Director of Operations for KVM Rehabilitation, a marketing and sales subsidiary of KVM which was sold in 1994. Prior to KVM he was in charge of engineering for the Total Artificial Heart Program at the Texas Heart Institute. He was a member of the Baylor/Rice Artificial Heart Program while attending Rice University where he received his BS in Mechanical and Aerospace Engineering degree.

Andrew Yee, Vice President of Product Development - Andrew has over 11 years of medical product research and development experience. He was responsible for project design and manufacturing of various medical devices used in the NASA space shuttle program and on Russia's MIR space station. These devices included cardiovascular imaging systems, physiological signal acquisition systems and centrifugal fluid handling systems. As Director of Product Development at Fairway, he is responsible for overseeing the technical aspects of product development, formulating and implementing the quality control system and ensuring regulatory compliance. He received a BS in Electrical Engineering from Northwestern University and an MBA and MS in Biomedical Engineering from Texas A&M.

Tom Miller, Vice President of Engineering - Tom has over 18 years of medical product engineering and development experience and came to Fairway as part of the KVM purchase in 2000. He was Vice President of KVM Technologies where he developed over 40 medical products in market areas encompassing: cardiovascular, immunology, microbiology, hematology, rehabilitation, drug-abuse, and a variety of specialty consulting areas. Prior to KVM he managed the Houston area service operations for Motorola Communications and Electronics, Inc. The Houston area service facilities consisted of fifty technicians, engineers and support personnel deployed in the installation and service of two-way radio communication systems. Prior to Motorola, Tom was a Process Control Engineer for Texas Instruments when they installed their first automated production line. Tom received his BS in Chemistry at Roanoke College and received extensive electronics and mechanical engineering training with the U.S. Navy Nuclear Propulsion Program.

Alexander A. Oraevsky, Ph.D., Vice President of Research and Development - Alexander has three patents and has published four book chapters and 70 scientific papers dealing with novel laser technologies applicable in biology and medicine. He is one of the inventors of the key patent for laser opto-acoustic imaging which was assigned to LaserSonix, Inc. a company he co-founded. It is around this platform technology which Fairway and LaserSonix Technologies have partnered. Alexander received his initial training in lasers and laser spectroscopy from the Moscow Physical and Engineering Institute, Moscow and obtained a doctorate in laser biophysics and biomedicine from the USSR Academy of Sciences, Moscow. Prior to coming to Fairway, he was an Assistant Professor at the University of Texas Medical Branch in Galveston, TX and a Faculty Fellow at Rice University. He moved permanently to the United States in 1991.

P. Mark Henrichs, Ph.D., Director of Technology Development - Mark has 30 years of experience in scientific research and medical technology, especially relating to medical imaging and chemical spectroscopy. He has worked for major chemical and pharmaceutical companies, including Kodak, Sterling Drug, Exxon and Nycomed Imaging (now Amersham). At Nycomed he was a Senior Fellow and the Discovery Project Leader for contrast agents relating to optical imaging. As the project progressed, he became excited about the potential for optoacoustic imaging to overcome the inherently low resolution of optical imaging while retaining its contrast strengths. Since leaving Amersham, he has worked to make optoacoustic imaging a clinical reality as President of LaserSonix Technologies, Inc., Fairway's partner for laser opto-acoustic imaging. He is the author of more than 60 scientific publications and has been listed as an inventor on over ten patent applications and issued patents. He has a BA in Chemistry from Rice University and a PhD in Organic Chemistry from UCLA.

In Memoriam, Greg Georges, President and C.E.O. - Greg had been with Fairway as President and CEO since December, 1996. He had over 25 years experience in the medical device industry, most of it in the cardiovascular/cardiology marketplace. Since 1985, he had been involved exclusively with start-up companies either as an executive or as a consultant serving in various roles. He was a member of the core management team of Kardiothor, Inc. (later Amnion), which was the first spin-off company formed by BCM Technologies, Inc. (BCMT is the technology transfer and venture development subsidiary of the Baylor College of Medicine). Kardiothor successfully commercialized the BRAT (Baylor Rapid Autologous Transfusion) System, which had originally been developed at The Methodist Hospital. Following the acquisition of Amnion by COBE Laboratories, Greg actively managed the transition of the product line to COBE, including to their international subsidiaries and distributors. He also served as V.P. of Marketing and Sales for Optex Biomedical, Inc., another start-up, high technology medical device company. He received a B.S in Engineering in 1968 and an MBA in 1972, both from Lehigh University.

In 2002 Greg was diagnosed with esophegal cancer. He fought his battle against the disease with honor, courage, and dignity. Through it all, his quick wit and gentle countenance comforted the scores of friends and family who surrounded him. The family would like to thank all of the medical personnel and friends who aided Greg in his struggle.